Enfermedades neurodegenerativas: desarrollo de terapias
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Vázquez C, Tolón RM, Pazos MR, Moreno M, Koester EC, Cravatt BF, Hillard CJ, Romero J.
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies
NEUROBIOLOGY OF DISEASE . 79: 41-50. Nº de citas: 30
-
Feliú A, Moreno-Martet M, Mecha M, Carrillo-Salinas FJ, de Lago E, Fernández-Ruiz J, Guaza C.
A Sativex((R))-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
BRITISH JOURNAL OF PHARMACOLOGY . 172(14, SI): 3579-3595. Nº de citas: 41
-
Espejo-Porras F, Piscitelli F, Verde R, Ramos JA, Di Marzo V, de Lago E, Fernández-Ruiz J.
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
JOURNAL OF NEUROIMMUNE PHARMACOLOGY . 10(2): 233-244. Nº de citas: 30
-
Bañón S, Rosillo M, Gómez A, Pérez-Elias MJ, Moreno S, Casado JL.
Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients
Endocrine . 49(2): 528-537. Nº de citas: 16
-
Perucho J, Gonzalo-Gobernado R, Bazan E, Casarejos MJ, Jiménez-Escrig A, Asensio MJ, Herranz AS.
Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC
Amino Acids . 47(5): 963-973. Nº de citas: 33
-
Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C, Zamora P.
Use of bevacizumab as a first-line treatment for metastatic breast cancer
Current Oncology . 22(2): 51-60. Nº de citas: 14
-
Morales P, Blasco-Benito S, Andradas C, Gómez-Cañas M, Flores JM, Goya P, Fernández-Ruiz J, Sánchez C, Jagerovic N.
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer
JOURNAL OF MEDICINAL CHEMISTRY . 58(5): 2256-2264. Nº de citas: 26
-
García MC, Cinquina V, Palomo-Garo C, Rábano A, Fernández-Ruiz J.
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson's disease
NEUROSCIENCE LETTERS . 587: 1-4. Nº de citas: 61
-
Fernández-Ruiz J, Romero J, Ramos JA.
Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Handbook of experimental pharmacology . 231: 233-259.
-
Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O.
Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
Neurotherapeutics . 12(1): 185-199. Nº de citas: 67
-
Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, Himmelreich U, Fernandez-Ruiz J, Bormans G, Van Laere K, Casteels C.
Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice
NEUROBIOLOGY OF AGING . 35(12): 2858-2869. Nº de citas: 24
-
Fernandes VS, Ribeiro AS, Martínez P, López-Oliva ME, Barahona MV, Orensanz LM, Martínez-Sáenz A, Recio P, Benedito S, Bustamante S, García-Sacristán A, Prieto D, Hernández M.
Hydrogen Sulfide Plays a Key Role in the Inhibitory Neurotransmission to the Pig Intravesical Ureter
Plos One . 9(11): . Nº de citas: 19
-
Calatrava-Ferreras L, Gonzalo-Gobernado R, Reimers D, Herranz AS, Jiménez-Escrig A, Díaz-Gil JJ, Casarejos MJ, Montero-Vega MT, Bazán E.
Neuroprotective Role of Liver Growth Factor ``LGF'' in an Experimental Model of Cerebellar Ataxia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 15(10): 19056-19073. Nº de citas: 4
-
Casarejos MJ, Perucho J, López-Sendón JL, García de Yébenes J, Bettencourt C, Gómez A, Ruiz C, Heutink P, Rizzu P, Mena MA.
Trehalose Improves Human Fibroblast Deficits in a New CHIP-Mutation Related Ataxia
Plos One . 9(9): . Nº de citas: 21
-
Moreno-Martet M, Espejo-Porras F, Fernández-Ruiz J, de Lago E.
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1(G93A) Transgenic Mice and Evaluation of a Sativex (R)-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
CNS NEUROSCIENCE & THERAPEUTICS . 20(9): 809-815. Nº de citas: 37
-
Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C.
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
JOURNAL OF BIOLOGICAL CHEMISTRY . 289(32): 21960-21972. Nº de citas: 71
-
Chiarlone A, Bellocchio L, Blázquez C, Resel E, Soria-Gómez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sánchez-Prieto J, Lutz B, Fernández-Ruiz J, Galve-Roperh I, Guzmán M.
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 111(22): 8257-8262. Nº de citas: 109
-
Ribeiro AS, Fernandes VS, Martínez MP, Martínez-Sáenz A, Pazos MR, Orensanz LM, Recio P, Bustamante S, Carballido J, García-Sacristán A, Prieto D, Hernández M.
Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle
NEUROUROLOGY AND URODYNAMICS . 33(5): 558-565. Nº de citas: 3